Media
Our latest press releases and resources for media
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
2021 Third quarter results announcement
We announced our third quarter results for the period ended 30 September 2021 on Wednesday 27 October.
Press releases for media
- GSK welcomes Gavi decision to fund the roll out of malaria vaccines for children
- MHRA grants conditional marketing authorisation1 for COVID-19 treatment Xevudy (sotrovimab)
- GSK and the University of Oxford launch new Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease
- Preclinical data demonstrate sotrovimab retains activity against key Omicron mutations, new SARS-CoV-2 variant
GSK Twitter
-
GSK @GSK
“A malaria vaccine is urgently needed given rising numbers of malaria cases in children in Africa. Gavi’s funding decision is a critical next step in ensuring access to the malaria vaccine for children who need it” Thomas Breuer, Chief Global Health Officer, GSK twitter.com/gavi/status/14…
about 12 hours ago -
GSK @GSK
#News for #investors and #media: @gavi announces funding for the roll out of #malaria vaccines, a critical next step in ensuring access to vaccines for children who need it. Find out more: gsk.to/2ZM91FN
about 12 hours ago
New GSK Investor update
Emma Walmsley, CEO, and other members of CET hosted a virtual investor update on Wednesday 23 June.
The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.
